207 related articles for article (PubMed ID: 11559645)
1. Reducing community dyspepsia drug costs: a controlled trial.
Valori RM; Brown CM; Strangeways P; Bradburn M
Gut; 2001 Oct; 49(4):495-501. PubMed ID: 11559645
[TBL] [Abstract][Full Text] [Related]
2. Problems with implementing guidelines: a randomised controlled trial of consensus management of dyspepsia.
Jones RH; Lydeard S; Dunleavey J
Qual Health Care; 1993 Dec; 2(4):217-21. PubMed ID: 10132454
[TBL] [Abstract][Full Text] [Related]
3. Influencing referral practice using feedback of adherence to NICE guidelines: a quality improvement report for dyspepsia.
Elwyn G; Owen D; Roberts L; Wareham K; Duane P; Allison M; Sykes A
Qual Saf Health Care; 2007 Feb; 16(1):67-70. PubMed ID: 17301208
[TBL] [Abstract][Full Text] [Related]
4. Fundholders' prescribing costs: the first five years.
Harris CM; Scrivener G
BMJ; 1996 Dec; 313(7071):1531-4. PubMed ID: 8978232
[TBL] [Abstract][Full Text] [Related]
5. Shifting physician prescribing to a preferred histamine-2-receptor antagonist. Effects of a multifactorial intervention in a mixed-model health maintenance organization.
Brufsky JW; Ross-Degnan D; Calabrese D; Gao X; Soumerai SB
Med Care; 1998 Mar; 36(3):321-32. PubMed ID: 9520957
[TBL] [Abstract][Full Text] [Related]
6. Medication prescribing advice and drug utilization: a review from the United Kingdom.
Law J; Thompson A
Pharm Pract Manag Q; 1996 Jan; 15(4):27-35. PubMed ID: 10153842
[TBL] [Abstract][Full Text] [Related]
7. Determinants of prescribing costs for ulcer-healing drugs and upper gastrointestinal endoscopy in general practice.
Asante MA; Mendall MA; Bland JM; Northfield TC
Eur J Gastroenterol Hepatol; 1998 Jul; 10(7):589-93. PubMed ID: 9855084
[TBL] [Abstract][Full Text] [Related]
8. Population-based and opportunistic screening and eradication of Helicobacter pylori. An analysis using trial baseline data. Leeds H. pylori Study Group.
Mason JM; Moayyedi P; Young PJ; Duffett S; Crocombe W; Drummond MF; Axon AT
Int J Technol Assess Health Care; 1999; 15(4):649-60. PubMed ID: 10645106
[TBL] [Abstract][Full Text] [Related]
9. Modifying dyspepsia management in primary care: a cluster randomised controlled trial of educational outreach compared with passive guideline dissemination.
Banait G; Sibbald B; Thompson D; Summerton C; Hann M; Talbot S;
Br J Gen Pract; 2003 Feb; 53(487):94-100. PubMed ID: 12817353
[TBL] [Abstract][Full Text] [Related]
10. Primary care groups and the right to prescribe.
Newdick C
BMJ; 1998 Nov; 317(7169):1361-4. PubMed ID: 9812936
[No Abstract] [Full Text] [Related]
11. Randomised controlled trial comparing cost effectiveness of general practitioners and nurse practitioners in primary care.
Venning P; Durie A; Roland M; Roberts C; Leese B
BMJ; 2000 Apr; 320(7241):1048-53. PubMed ID: 10764367
[TBL] [Abstract][Full Text] [Related]
12. The impact of a general practice group intervention on prescribing costs and patterns.
Walker J; Mathers N
Br J Gen Pract; 2002 Mar; 52(476):181-6. PubMed ID: 12030659
[TBL] [Abstract][Full Text] [Related]
13. Use of H2-receptor antagonists in patients with dyspepsia and heartburn: a cost comparison.
Goulston KJ; Dent OF; Mant A; Logan J; Ngu M
Med J Aust; 1991 Jul; 155(1):20-6. PubMed ID: 1676825
[TBL] [Abstract][Full Text] [Related]
14. Cost analysis of a provincial drug program to guide the treatment of upper gastrointestinal disorders.
Bursey F; Crowley M; Janes C; Turner CJ
CMAJ; 2000 Mar; 162(6):817-23. PubMed ID: 10750472
[TBL] [Abstract][Full Text] [Related]
15. Prescribing costs. Braking point.
Reid E; Cooke J; Johnson R; McKnight H
Health Serv J; 2000 May; 110(5705):28-30. PubMed ID: 11183327
[TBL] [Abstract][Full Text] [Related]
16. Impact of Helicobacter pylori eradication on dyspepsia, health resource use, and quality of life in the Bristol helicobacter project: randomised controlled trial.
Lane JA; Murray LJ; Noble S; Egger M; Harvey IM; Donovan JL; Nair P; Harvey RF
BMJ; 2006 Jan; 332(7535):199-204. PubMed ID: 16428249
[TBL] [Abstract][Full Text] [Related]
17. Rational prescribing in primary care (RaPP): economic evaluation of an intervention to improve professional practice.
Fretheim A; Aaserud M; Oxman AD
PLoS Med; 2006 Jun; 3(6):e216. PubMed ID: 16737349
[TBL] [Abstract][Full Text] [Related]
18. Impact of an interest in asthma on prescribing costs in general practice.
Jones K
Qual Health Care; 1992 Jun; 1(2):110-3. PubMed ID: 10136839
[TBL] [Abstract][Full Text] [Related]
19. Do general practices which provide an acupuncture service have low referral rates and prescription costs? A pilot survey.
Johnson G; White A; Livingstone R
Acupunct Med; 2008 Dec; 26(4):205-13. PubMed ID: 19098691
[TBL] [Abstract][Full Text] [Related]
20. Dutch GPs' perceptions: the influence of out-of-pocket costs on prescribing.
Kasje WN; Timmer JW; Boendermaker PM; Haaijer-Ruskamp FM
Soc Sci Med; 2002 Nov; 55(9):1571-8. PubMed ID: 12297243
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
